Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1976 1
1977 1
1979 1
1981 2
1983 4
1985 1
1986 2
1988 4
1989 4
1990 3
1991 1
1992 5
1993 5
1994 6
1995 2
1996 6
1997 8
1998 4
1999 11
2000 5
2001 10
2002 16
2003 7
2004 11
2005 10
2006 16
2007 11
2008 10
2009 16
2010 10
2011 13
2012 20
2013 20
2014 24
2015 22
2016 22
2017 25
2018 26
2019 30
2020 36
2021 23
Text availability
Article attribute
Article type
Publication date

Search Results

417 results
Results by year
Filters applied: . Clear all The following terms were ignored: %, %, %, % The following terms were not found in PubMed: 22Lok, 5BAuthor
Page 1
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
Cauchois R, Koubi M, Delarbre D, Manet C, Carvelli J, Blasco VB, Jean R, Fouche L, Bornet C, Pauly V, Mazodier K, Pestre V, Jarrot PA, Dinarello CA, Kaplanski G. Cauchois R, et al. Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):18951-18953. doi: 10.1073/pnas.2009017117. Epub 2020 Jul 22. Proc Natl Acad Sci U S A. 2020. PMID: 32699149 Free PMC article.
Because interleukin-1 (IL-1) blocks the production of IL-6 and other proinflammatory cytokines, we treated COVID-19 patients early in the disease with the IL-1 receptor antagonist, anakinra. We retrospectively compared 22 patients from three different centers in France wit …
Because interleukin-1 (IL-1) blocks the production of IL-6 and other proinflammatory cytokines, we treated COVID-19 patients early in the di …
Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients.
Arifin B, Purba FD, Herman H, Adam JMF, Atthobari J, Schuiling-Veninga CCM, Krabbe PFM, Postma MJ. Arifin B, et al. Health Qual Life Outcomes. 2020 Feb 7;18(1):22. doi: 10.1186/s12955-020-1282-y. Health Qual Life Outcomes. 2020. PMID: 32028954 Free PMC article.
Two versions of the EQ-5D are available: the 3-level version (EQ-5D-3 L) and the 5-level version (EQ-5D-5 L). This study aims to compare specific measurement properties and scoring of the EQ-5D-3 L (3 L) and EQ-5D-5 …
Two versions of the EQ-5D are available: the 3-level version (EQ-5D-3 L) and the 5-level version (EQ-5D-5 L
Complications and outcome after rib fracture fixation: A systematic review.
Peek J, Beks RB, Hietbrink F, Heng M, De Jong MB, Beeres FJP, Leenen LPH, Groenwold RHH, Houwert RM. Peek J, et al. J Trauma Acute Care Surg. 2020 Aug;89(2):411-418. doi: 10.1097/TA.0000000000002716. J Trauma Acute Care Surg. 2020. PMID: 32282759
The most frequently used questionnaire to assess patient quality of life was the EuroQol-5D (EQ-5D) (n = 4). Four studies reporting on the EQ-5D had a weighted mean EQ-5D index of 0.80 indicating good quality of life after rib fracture fixation. ...
The most frequently used questionnaire to assess patient quality of life was the EuroQol-5D (EQ-5D) (n = 4). Four studies repo …
Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins.
Brittenden J, Cooper D, Dimitrova M, Scotland G, Cotton SC, Elders A, MacLennan G, Ramsay CR, Norrie J, Burr JM, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, Tassie E, Francis J, Campbell MK. Brittenden J, et al. N Engl J Med. 2019 Sep 5;381(10):912-922. doi: 10.1056/NEJMoa1805186. N Engl J Med. 2019. PMID: 31483962 Free article. Clinical Trial.
Primary outcomes at 5 years were disease-specific quality of life and generic quality of life, as well as cost-effectiveness based on models of expected costs and quality-adjusted life-years (QALYs) gained that used data on participants' treatment costs and scores on the EuroQol …
Primary outcomes at 5 years were disease-specific quality of life and generic quality of life, as well as cost-effectiveness based on models …
Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial.
Lai Y, Huang J, Yang M, Su J, Liu J, Che G. Lai Y, et al. J Surg Res. 2017 Mar;209:30-36. doi: 10.1016/j.jss.2016.09.033. Epub 2016 Sep 28. J Surg Res. 2017. PMID: 28032568 Clinical Trial.

During the preoperative PR, a significantly longer 6-MWD (increase: 28.6 18.2 versus 9.4 27.0 m; between-groups difference: 19.2 m, P = 0.029) and an increased PEF (increase: 26.2 22.5 versus 8.2 10.3 L/min; between-groups difference: 18.0 L/min, P < 0.001

During the preoperative PR, a significantly longer 6-MWD (increase: 28.6 18.2 versus 9.4 27.0 m; between-groups difference: 19.2 m, P = 0.02 …
A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain.
Ye Z, Sun L, Wang Q. Ye Z, et al. Health Qual Life Outcomes. 2019 Apr 11;17(1):57. doi: 10.1186/s12955-019-1137-6. Health Qual Life Outcomes. 2019. PMID: 30971265 Free PMC article.
EQ-5D-5 L demonstrated better performance for most groups except location and general health grouped by the general assessment of health item from SF-36. Furthermore, when we applied ODI as external indicator of health status, the area under the ROC curve for EQ- …
EQ-5D-5 L demonstrated better performance for most groups except location and general health grouped by the general assessment …
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Oza AM, Matulonis UA, Malander S, Hudgens S, Sehouli J, Del Campo JM, Berton-Rigaud D, Banerjee S, Scambia G, Berek JS, Lund B, Tinker AV, Hilpert F, Vázquez IP, D'Hondt V, Benigno B, Provencher D, Buscema J, Agarwal S, Mirza MR. Oza AM, et al. Lancet Oncol. 2018 Aug;19(8):1117-1125. doi: 10.1016/S1470-2045(18)30333-4. Epub 2018 Jul 17. Lancet Oncol. 2018. PMID: 30026000 Clinical Trial.
In this study, we assessed patient-reported outcomes (PROs) in the intention-to-treat population using the Functional Assessment of Cancer Therapy-Ovarian Symptoms Index (FOSI) and European QOL five-dimension five-level questionnaire (EQ-5D-5L). We collected PROs from tria …
In this study, we assessed patient-reported outcomes (PROs) in the intention-to-treat population using the Functional Assessment of Cancer T …
The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand.
Abedini MR, Bijari B, Miri Z, Shakhs Emampour F, Abbasi A. Abedini MR, et al. Health Qual Life Outcomes. 2020 Jan 30;18(1):18. doi: 10.1186/s12955-020-1277-8. Health Qual Life Outcomes. 2020. PMID: 32000785 Free PMC article.
Data were collected using a checklist including patients' demographic, clinical and laboratory information and the EQ-5D-5 L. Data were entered the SPSS (22) software, analyzed by independent sample T-test, ANOVA, Chi-Square and logistic regression tests. ... …
Data were collected using a checklist including patients' demographic, clinical and laboratory information and the EQ-5D-5 L. …
Intramedullary nail fixation versus locking plate fixation for adults with a fracture of the distal tibia: the UK FixDT RCT.
Costa ML, Achten J, Hennings S, Boota N, Griffin J, Petrou S, Maredza M, Dritsaki M, Wood T, Masters J, Pallister I, Lamb SE, Parsons NR. Costa ML, et al. Health Technol Assess. 2018 May;22(25):1-148. doi: 10.3310/hta22250. Health Technol Assess. 2018. PMID: 29785926 Free PMC article. Clinical Trial.
The secondary outcomes were the Olerud-Molander Ankle Score (OMAS), quality of life as measured using EuroQol-5 Dimensions (EQ-5D), complications such as infection, and further surgery. Resource use was collected to inform the health economic evaluation. ...FUNDING: This p …
The secondary outcomes were the Olerud-Molander Ankle Score (OMAS), quality of life as measured using EuroQol-5 Dimensions (EQ-5D), c …
417 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page